Completing data — refresh the page later to see the latest
45267-19-4CCCCCCCCCCCCCC(=O)NCCCN(C)CIFYDWYVPVAMGRO-UHFFFAOYSA-NThe CIR Expert Panel concluded that the 24 fatty acid amidopropyl dimethylamines ingredients listed below are safe in cosmetics when they are formulated to be non-sensitizing, which may be based on a QRA...Myristamidopropyl Dimethylamine...
45267-19-4DTXSID2068470Cosmetic ingredients (Myristamidopropyl Dimethylamine) -> CIR (Cosmetic Ingredient Review)
Antistatic
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 0.8% (1 of 128) of reports.
Danger
H315 (98.4%): Causes skin irritation [Warning Skin corrosion/irritation]
P264, P264+P265, P280, P302+P352, P305+P354+P338, P317, P321, P332+P317, and P362+P364 (click each P-code to see the statement)
Aggregated GHS information provided per 128 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Warning
Chemical: Tetradecanamide, N-[3-(dimethylamino)propyl]-
Tetradecanamide, N-[3-(dimethylamino)propyl]- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Tetradecanamide, N-[3-(dimethylamino)propyl]- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Skin Irrit. 2 (98.4%)
Skin corrosion - category 1
The CIR Expert Panel concluded that the 24 fatty acid amidopropyl dimethylamines ingredients listed below are safe in cosmetics when they are formulated to be non-sensitizing, which may be based on a QRA...Myristamidopropyl Dimethylamine...
Safe for use in cosmetics, with qualifications
All Other Basic Organic Chemical Manufacturing
Tetradecanamide, N-[3-(dimethylamino)propyl]-: ACTIVE
UsesMyristamidopropyl dimethylamine (MAPD), present as Aldox in Opti-Free Express Disinfecting Solution for contact lens care, was tested for its potential as a drug in treatment of Acanthamoeba keratitis. MAPD is an amidoamine compound that shows activity against Acanthamoeba as well as a variety of other causal agents of microbial keratitis.
Loading…